These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2934942)

  • 21. [Leukotrienes and the lung].
    Leitch AG
    Rev Mal Respir; 1984; 1(6):329-36. PubMed ID: 6099600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine.
    Tauber AI; Kaliner M; Stechschulte DJ; Austen KF
    J Immunol; 1973 Jul; 111(1):27-32. PubMed ID: 4123374
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interaction of various leukotrienes in guinea pig tracheal and lung parenchymal strips].
    Uchida Y; Ishihara Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):542-7. PubMed ID: 2997531
    [No Abstract]   [Full Text] [Related]  

  • 24. Differentiation of the tracheal and lung parenchymal effects of synthetic leukotrienes in the guinea pig.
    Wasserman MA; Weichman BM; Woodward DF; Muccitelli RM; Gleason JG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():133-7. PubMed ID: 6303081
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of the synthesis and release of slow-reacting substance of anaphylaxis from sensitized monkey lung.
    Weichman BM; Hostelley LS; Bostick SP; Muccitelli RM; Krell RD; Gleason JG
    J Pharmacol Exp Ther; 1982 May; 221(2):295-302. PubMed ID: 6176708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ["Slow reacting substance of anaphylaxis": biochemical characterization and new prospects for the treatment of asthma and other allergic diseases (author's transl)].
    Boeynaems JM; Delespesse G
    Rev Med Brux; 1981 Nov; 2(9):803-9. PubMed ID: 6798664
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological evaluation of mediators released on anaphylaxis in the trachea and peripheral lung of guinea pigs].
    Ohtsuka M; Uchida Y; Nomura A; Inoue M; Hamada M; Yamashita Y; Ishii Y; Hasegawa S; Goto K
    Arerugi; 1988 Jan; 37(1):27-39. PubMed ID: 3377690
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic releas of histamine an slow-reacting substance of anaphylaxis (SRS-A).
    Orange RP; Stechschulte DJ; Austen KF
    J Immunol; 1970 Nov; 105(5):1087-95. PubMed ID: 4099046
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effects of Ca++ antagonists nifedipine and nicardipine on slow reacting substance of anaphylaxis (SRS-A) mediated bronchoconstriction in guinea pig].
    Koshino T
    Arerugi; 1984 Jan; 33(1):6-16. PubMed ID: 6743030
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of calcium antagonists on leukotriene D4-induced contractions of the guinea-pig trachea and lung parenchyma.
    Weichman BM; Muccitelli RM; Tucker SS; Wasserman MA
    J Pharmacol Exp Ther; 1983 May; 225(2):310-5. PubMed ID: 6842394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FPL 55712--an antagonist of slow reacting substance of anaphylaxis (SRS-A): a review. 1979.
    Chand N
    Agents Actions; 1994 Dec; 43(3-4):168-75; discussion 167. PubMed ID: 7725968
    [No Abstract]   [Full Text] [Related]  

  • 32. On the preparation of highly purified slow reacting substance of anaphylaxis (SRS-A) from biological extracts [proceedings].
    Blackwell GL; Burka JF; Flower RJ
    Br J Pharmacol; 1978 Jun; 63(2):365P-366P. PubMed ID: 566598
    [No Abstract]   [Full Text] [Related]  

  • 33. Slow-reacting substance of anaphylaxis: purification and characterisation.
    Morris HR; Taylor GW; Piper PJ; Sirois P; Tippins JR
    FEBS Lett; 1978 Mar; 87(2):203-6. PubMed ID: 631337
    [No Abstract]   [Full Text] [Related]  

  • 34. Slow-reacting substance of anaphylaxis antagonist FPL 55712 in chronic asthma.
    Lee TH; Walport MJ; Wilkinson AH; Turner-Warwick M; Kay AB
    Lancet; 1981 Aug; 2(8241):304-5. PubMed ID: 6114343
    [No Abstract]   [Full Text] [Related]  

  • 35. Nicardipine suppresses bronchoconstrictor actions of pharmacologic agents in guinea pigs.
    Zhang HQ; Lai YL
    Lung; 1991; 169(6):343-55. PubMed ID: 1758203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-slow reacting substance of anaphylaxis effect of verapamil].
    Zhang HQ; Bian RL
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):110-2. PubMed ID: 2934942
    [No Abstract]   [Full Text] [Related]  

  • 37. [The anti-SRS-A effect of tetrandrine].
    Zhang HQ; Bian RL
    Yao Xue Xue Bao; 1984 Aug; 19(8):616-8. PubMed ID: 6536169
    [No Abstract]   [Full Text] [Related]  

  • 38. Unique modulation of the immunological release of slow-reacting substance of anaphylaxis (SRS-A) from bovine lung.
    Burka JF; Eyre P
    Monogr Allergy; 1977; 12():241-4. PubMed ID: 335217
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on slow reacting substance (SRS). Comparison of naturally occurring, radiolabeled SRS and synthetic leukotriene D4 (LTD4) on high performance liquid chromatography, and of partially purified SRS-A and LTD4 on the activity of smooth muscle preparations of guinea pig].
    Watanabe-Kohno S; Kiso S; Ohata K
    Arerugi; 1983 Jan; 32(1):46-56. PubMed ID: 6134518
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Tomioka K; Yamada T; Mase T; Hara H; Murase K
    Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.